Carisoprodol Tablet
Product Images NDC 50742-656

4 FDA label images from Ingenus Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 50742-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure001)

Structure (Structure001)
Chemical structure of carisoprodol, the active ingredient in CARISOPRODOL tablets 350 mg by Ingenus Pharmaceuticals, LLC. The diagram shows the molecular arrangement including functional groups and bonds.*
FDA Label Image
FDA Label Image

100's Label (100ct Bottle Label)

100's Label (100ct Bottle Label)
Label for Carisoprodol Tablets, USP 350 mg, oral tablet manufactured for Ingenus Pharmaceuticals, LLC. The label indicates the product contains 100 tablets, is prescription-only (Rx Only), and includes dosing and storage instructions. The NDC number shown is 50742-656-01.*
FDA Label Image

500's Label (500ct Bottle Label)

500's Label (500ct Bottle Label)
The label for Carisoprodol Tablets, USP 350 mg oral tablets from Ingenus Pharmaceuticals, LLC. It is prescription only and the package contains 500 tablets. The label includes storage instructions and warnings, emphasizing keeping out of children's reach and dispensing in a tight, light-resistant container. The NDC is 50742-656-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.